← The frontier
Science & ResearchSep 6, 2026

The changing therapeutic landscape of small-cell lung cancer.

Small-cell lung cancer (SCLC) is an exceptionally aggressive malignancy: highly proliferative, heterogeneous, and frequently metastatic at diagnosis.

Small-cell lung cancer (SCLC) is an exceptionally aggressive malignancy: highly proliferative, heterogeneous, and frequently metastatic at diagnosis. Although initially responsive to chemotherapy, such responses are typically transient, and recurrent disease has been largely…

The frontier is open to all. Sign in to learn this from first principles and save it to your knowledge base.